|
ASML
|
Technology |
BerenbergD |
Upgrade
|
Hold
→
Buy
|
—
|
$602.8B
|
$91.91
|
+0.6%
|
+0.1%
|
-1.0%
|
-2.0%
|
+1.6%
|
+2.3%
|
|
NVO
|
Healthcare |
Leerink Swann |
Maintains
|
Market Perform
→
Perform
|
—
|
$197.0B
|
$28.08
|
-0.7%
|
-0.7%
|
-0.8%
|
-2.0%
|
+2.1%
|
-0.4%
|
|
SAN
|
Financial Services |
Deutsche BankB |
Upgrade
|
Hold
→
Buy
|
—
|
$187.6B
|
$5.97
|
-1.0%
|
-0.5%
|
-1.7%
|
-3.3%
|
+0.5%
|
-1.1%
|
|
CRM
|
Technology |
Exane BNP ParibasC |
Upgrade
|
Neutral
→
Outperform
|
—
|
$171.5B
|
$69.94
|
-0.3%
|
+0.4%
|
-1.3%
|
-3.9%
|
+2.0%
|
+0.4%
|
|
CVS
|
Healthcare |
Oppenheimer |
Maintains
|
Outperform
→
Outperform
|
—
|
$119.7B
|
$105.20
|
+0.2%
|
-1.0%
|
-1.7%
|
-2.1%
|
+0.8%
|
+0.5%
|
|
GM
|
Consumer Cyclical |
Piper Sandler |
Maintains
|
Overweight
→
Overweight
|
—
|
$70.7B
|
$28.58
|
+0.1%
|
+1.5%
|
+1.5%
|
-2.7%
|
+2.0%
|
-0.3%
|
|
ADSK
|
Technology |
Canaccord Genuity |
Maintains
|
Buy
→
Buy
|
—
|
$52.4B
|
$50.00
|
-4.5%
|
-5.0%
|
-1.6%
|
-2.7%
|
+1.1%
|
-0.1%
|
|
ADSK
|
Technology |
Barclays |
Maintains
|
Overweight
→
Overweight
|
—
|
$52.4B
|
$50.00
|
-4.5%
|
-5.0%
|
-1.6%
|
-2.7%
|
+1.1%
|
-0.1%
|
|
ADSK
|
Technology |
Wedbush |
Maintains
|
Neutral
→
Neutral
|
—
|
$52.4B
|
$50.00
|
-4.5%
|
-5.0%
|
-1.6%
|
-2.7%
|
+1.1%
|
-0.1%
|
|
ADSK
|
Technology |
RBC Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$52.4B
|
$50.00
|
-4.5%
|
-5.0%
|
-1.6%
|
-2.7%
|
+1.1%
|
-0.1%
|
|
ADSK
|
Technology |
UBS |
Maintains
|
Buy
→
Buy
|
—
|
$52.4B
|
$50.00
|
-4.5%
|
-5.0%
|
-1.6%
|
-2.7%
|
+1.1%
|
-0.1%
|
|
ETR
|
Utilities |
Barclays |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$49.8B
|
$32.91
|
-0.1%
|
+0.1%
|
-0.8%
|
-3.5%
|
-0.5%
|
+0.4%
|
|
IDXX
|
Healthcare |
Raymond James |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$44.1B
|
$73.42
|
-2.0%
|
-0.3%
|
-2.4%
|
-1.3%
|
+3.4%
|
+0.1%
|
|
TCOM
|
Consumer Cyclical |
StifelA+ |
Upgrade
|
Hold
→
Buy
|
—
|
$34.2B
|
$34.98
|
+0.2%
|
-0.7%
|
-4.4%
|
-3.2%
|
+1.8%
|
+0.7%
|
|
VEEV
|
Healthcare |
Canaccord Genuity |
Maintains
|
Buy
→
Buy
|
—
|
$27.3B
|
$24.16
|
-0.3%
|
+9.4%
|
-2.0%
|
-4.7%
|
+0.2%
|
-0.6%
|
|
VEEV
|
Healthcare |
UBS |
Maintains
|
Buy
→
Buy
|
—
|
$27.3B
|
$24.16
|
-0.3%
|
+9.4%
|
-2.0%
|
-4.7%
|
+0.2%
|
-0.6%
|
|
RF
|
Financial Services |
GuggenheimC |
Upgrade
|
Neutral
→
Buy
|
—
|
$23.6B
|
$9.56
|
-0.5%
|
+0.6%
|
-0.3%
|
-4.0%
|
+1.4%
|
+1.0%
|
|
IHG
|
Consumer Cyclical |
Credit SuisseB |
Upgrade
|
Neutral
→
Outperform
|
—
|
$23.4B
|
$41.43
|
-0.7%
|
+1.1%
|
-1.2%
|
-3.1%
|
+1.3%
|
+0.9%
|
|
HBAN
|
Financial Services |
GuggenheimC |
Upgrade
|
Neutral
→
Buy
|
—
|
$23.3B
|
$10.86
|
-0.1%
|
+0.5%
|
+0.0%
|
-4.2%
|
+1.3%
|
+1.1%
|
|
DG
|
Consumer Defensive |
Barclays |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$22.9B
|
$74.27
|
+0.3%
|
+0.8%
|
-0.5%
|
-3.6%
|
+0.6%
|
-0.1%
|